Clinical trials have four phases that test the safety and efficacy of various medical treatments on participants. Health insurance may cover some or all of the cost of participating in a clinical ...

Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients in the ...

Amy and Joseph Perella Professor of Medicine (Medical Oncology); Chief, Experimental Therapeutics; Associate Cancer Center Director, Experimental Therapeutics Pat LoRusso brings more than 25 years of ...

SynOx Therapeutics completed enrollment for the phase 3 TANGENT study of emactuzumab for tenosynovial giant cell tumors, with results expected in 2026. ALX Oncology launched a phase 1 trial of ALX2004 ...

ILLUMINATE Phase 2 pivotal study will enroll patients at six leading pediatric oncology centers across the U.S. B7-H3-targeted autologous CAR T cell therapy offers new treatment for diffuse intrinsic ...

EVO756 is a first-in-class, potent and highly selective oral small molecule antagonist of Mas-related G protein-coupled receptor X2 (MRGPRX2), a receptor predominantly found on mast cells and ...

NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.

US policymakers have proposed reforms in an attempt to replicate Australia’s success in facilitating speedy Phase 1 clinical ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...